THE PSORIATIC ARTHRITIS 5-THERMOMETER SCALES (PSA-5TS): A NEW INSTRUMENT FOR ASSESSING THE STATUS OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS

被引:2
|
作者
Salaffi, F. [1 ]
Carotti, M. [2 ]
Farah, S. [1 ]
Di Carlo, M. [1 ]
机构
[1] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Osped Carlo Urbani, Jesi, Italy
[2] Univ Politecn Marche, Dipartimento Sci Radiol, Osped Riuniti, Jesi, Italy
关键词
D O I
10.1136/annrheumdis-2022-eular.1829
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0010
引用
收藏
页码:218 / 219
页数:2
相关论文
共 50 条
  • [21] DISEASE ACTIVITY AND PATIENT CHARACTERISTICS BY COMORBIDITY AMONG PSORIATIC ARTHRITIS (PSA) PATIENTS IN A US REGISTRY
    Mease, P. J.
    Litman, H. J.
    Accortt, N. A.
    Rebello, S.
    Greenberg, J. D.
    Feng, H.
    Gharaibeh, M. M.
    Aras, G. A.
    Collier, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 380 - 381
  • [22] THE WORK PRODUCTIVITY AND ACTIVITY INDEX SPECIFIC HEALTH PROBLEM (WPAI-SHP) AND ITS ASSOCIATION WITH PSORIATIC ARTHRITIS (PSA) ACTIVITY BY DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA) IN ROUTINE CARE: DATA OF THE RUSSIAN PSORIATIC ARTHRITIS REGISTRY (RU-PSART)
    Korotaeva, T.
    Loginova, E.
    Koltakova, A.
    Gubar, E.
    Korsakova, Y.
    Nasonov, E.
    Lila, A.
    Sedunova, M.
    Salnikova, T.
    Umnova, I.
    Bondareva, I.
    Zagidulina, G.
    Zemtzova, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1042 - 1043
  • [23] DISEASE ACTIVITY STATES OF THE DAPSA, A PSORIATIC ARTHRITIS SPECIFIC INSTRUMENT, ARE VALID AGAINST THE CONSTRUCTS OF FUNCTIONAL STATUS AND STRUCTURAL PROGRESSION
    Aletaha, D.
    Alasti, F.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 646 - 647
  • [24] To compare the DAS-28 and the CPDAI (Composite Psoriatic Disease Activity Index) in predicting treatment change in Psoriatic Arthritis (PsA) patients
    Mumtaz, A.
    Gallagher, P.
    Veale, D. J.
    FitzGerald, O.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S563 - S563
  • [25] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    VALUE IN HEALTH, 2014, 17 (07) : A373 - A373
  • [26] Assessing the Validity of the Multi-Biomarker Disease Activity Assay in Patients with Psoriatic Arthritis
    Boyd, Tristan
    Huynh, Doquyen H.
    Eastman, P. Scott
    Qureshi, Ferhan
    Sasso, Eric H.
    Bolce, Rebecca J.
    Hillman, Joshua
    Boyle, David L.
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [27] A New and Simpler Tool for Global Psoriatic Arthritis Assessment: Simplified Composite Psoriatic Disease Activity Index (sCPDAI)
    Acosta Felquer, Maria Laura
    Elmamoun, Musaab
    Szentpetery, Agnes
    Gallagher, Phil
    FitzGerald, Oliver
    Soriano, Enrique R.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [28] Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction
    Choquette, Denis
    Thorne, Carter
    Khraishi, Majed
    Fortin, Isabelle
    Arendse, Regan
    Chow, Andrew
    Kelsall, John
    Baker, Milton
    Vaillancourt, Julie
    Sampalis, John
    Nantel, Francois
    Lehman, Allen
    Otawa, Susan
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1299 - 1299
  • [29] Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction
    Choquette, Denis
    Thorne, Carter
    Khraishi, Majed
    Fortin, Isabelle
    Arendse, Regan
    Chow, Andrew
    Kelsall, John
    Baker, Milton
    Vaillancourt, Julie
    Sampalis, John S.
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Shawi, May
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S683 - S684
  • [30] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) RECEIVING THEIR FIRST BIOLOGIC IN UK, GERMANY, FRANCE, ITALY AND SPAIN (5EU)
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baskett, A.
    VALUE IN HEALTH, 2013, 16 (03) : A219 - A219